Benchmark Holdings PLC Trading Statement (4366N)
October 26 2016 - 1:00AM
UK Regulatory
TIDMBMK
RNS Number : 4366N
Benchmark Holdings PLC
26 October 2016
Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
Trading Update and Notice of Results
Benchmark, the aquaculture biotechnology and food chain
sustainability business, announces that it expects Group
performance for the year ended 30 September 2016 to be in line with
the Board's expectations.
The integration of INVE is on plan, with the key account
management programme progressing well and work on the first
co-developed products has commenced.
The ongoing effect of El Niño in South East Asia and Latin
America, and disease challenge coupled with low market prices in
the shrimp sector, is resulting in delayed sector investment and
lower growth rates in the short term in both regions. The Group
intends to proceed cautiously with new investments until there is
more visibility on early sales, whilst continuing to progress core
infrastructure projects which support long term growth such as the
state of the art vaccine facility at Braintree which is now
entering the commissioning phase.
The Group is focussing on growing sales and market share in
developing markets, including China, for its Breeding and Genetics
and Advanced Animal Nutrition Divisions, and is actively exploring
routes to market and strategic relationships in those regions.
The long term drivers of growth in the Company's sectors, which
include the growing global demand for aquaculture products and an
ever increasing pressure to limit the use of antibiotics in the
food chain, are clearly positive. Benchmark offers an integrated
package of both products and services to its customers, and they
are increasingly recognising the significant value that this can
deliver in terms of driving their productivity, sustainability and
profitability.
Benchmark expects to announce its full year results for the 12
months to 30 September 2016 on Tuesday, 24 January 2017.
Commenting on trading, Benchmark's Chief Executive Officer,
Malcolm Pye, said:
"I am pleased to announce that the Group has delivered a solid
performance in line with expectations, in a challenging but
transformational year. We continue to execute our strategy to
deploy world-leading technology through established distribution
chains into long term growth markets, and our pipeline of products
in development continues to progress well. "
-Ends-
For further information,
please contact:
Benchmark Holdings plc Tel: 020 7920 3150
Malcolm Pye, CEO
Roland Bonney, COO
Rachel Aninakwah, Communications
Numis Tel: 020 7260 1000
Michael Meade / Freddie Barnfield
(NOMAD)
James Black (Corporate Broking)
Tavistock Tel: 020 7920 3150
Matt Ridsdale / Niall Walsh
Notes to Editors:
Founded in 2000, Benchmark challenges the status quo in
aquaculture, agriculture and animal healthcare.
The company has proven distribution capabilities in high growth
markets and through these it provides world leading: Products -
through an integrated package of high genetic merit breeding stock,
next era vaccines, pharmaceuticals and biocides and advanced
nutrition diets for the early stages of production; Manufacturing -
delivering cutting-edge technologies in animal health vaccines,
aquaculture breeding production facilities /technology and
state-of-the-art advanced nutrition product manufacturing; Services
- from veterinary clinical and diagnostic to technical in field/on
farm support and genetic programme management; Knowledge - through
consultancy, professional training, technical online & book
publishing and data management systems; Research - into major
health and management challenges facing aquaculture, agriculture
and animal health care informing the development of the group's
medicines, vaccines and management technologies.
Benchmark operates internationally with offices in England,
Scotland, Belgium, Ireland, Norway, Iceland, USA, Brazil, China,
Russia, Portugal, Thailand and Chile. As at 30 September 2016,
Benchmark employed 891 people.
For further information on Benchmark please visit
www.benchmarkplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTEELFLQBFEFBB
(END) Dow Jones Newswires
October 26, 2016 02:00 ET (06:00 GMT)
Benchmark (LSE:BMK)
Historical Stock Chart
From Apr 2024 to May 2024
Benchmark (LSE:BMK)
Historical Stock Chart
From May 2023 to May 2024